EMDR Intervention for Psychological Trauma Among Syrian Refugees

August 7, 2013 updated by: Ceren Acarturk, Istanbul Sehir University

EMDR Treatment for Psychological Trauma Among Syrian Refugees in Kilis, Randomized Controlled Trial.

To implement an EMDR (Eye Movement Desensitization and Reprocessing)intervention to treat the trauma symptoms among Syrian Refugees.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

In this project we aim to treat the posttraumatic stress disorder (PTSD) symptoms among Syrian refugees through an effective psycho-therapy technique called Eye Movement Desensitization and Reprocessing (EMDR). Randomly selected refugees will be assessed through MINI PLUS for the diagnose of PTSD. Eighty refugees with PTSD will be randomly allocated to either 7 sessions EMDR or wait-list control group.Symptoms of PTSD (MINI PLUS, HTQ, IES-R) and depression and anxiety (BDI, HSCL)will be assessed at pre- and post-treatment and 4 weeks follow-up.

However, to our knowledge this is one of the first intervention studies which will be conducted in a refugee camp. Therefore we expect to have some practical and logical problems. In order to see the feasibility and efficacy of EMDR among Syrian refugees, before the main study we aim to run a pilot study with less participants. In the pilot we will assess the posttraumatic stress symptoms with Impact of Event Scale-Revised (IES-R) and the depressive symptoms through Beck Depression Inventory (BDI-II).

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Gaziantep, Turkey
        • Recruiting
        • Kilis Camp for Refugees
        • Contact:
        • Principal Investigator:
          • Mustafa Cetinkaya, MA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • trauma symptoms

Exclusion Criteria:

  • pregnancy
  • current or past psychotic disorder
  • current or past substance abuse or dependence
  • serious physical illness
  • active suicidal ideation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EMDR intervention
40 participants with trauma symptoms will be randomly assigned to treatment group and receive EMDR intervention for trauma symptoms.EMDR is a trauma focused therapy starts with resource development and continue with bilateral stimulation while working on the most troubling traumatic memory.
Behavioral: Eye Movement Desensitization and Reprocessing Therapy
No Intervention: Waiting List
40 participants with trauma symptoms will be randomly assigned to waiting list as the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
score on Harvard Trauma Questionnaire (at the main study)
Time Frame: before and after the treatment,an expected average of 7 weeks of EMDR treatment
The change in HTQ score will be assessed after the EMDR treatment has finished after 7 weeks(estimated).
before and after the treatment,an expected average of 7 weeks of EMDR treatment
Impact of Event Scale Revised (at the pilot study and the main study)
Time Frame: pre- and post treatment
The change in IES-R score will be assessed after the EMDR treatment has finished after 7 weeks(estimated).
pre- and post treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
score on HSCL for depressive and anxiety symptoms (at the main study)
Time Frame: before and after the treatment, an expected average of 7 weeks of EMDR treatment
The change in HSCL score will be assessed after the EMDR treatment has finished in 7 weeks in average.
before and after the treatment, an expected average of 7 weeks of EMDR treatment
Score on BDI-II (pilot study and the main study)
Time Frame: before and after EMDR treatment, an expected average of 7 weeks of EMDR treatment
A change in BDI-II will be assessed after the EMDR treatment has completed in 7 weeks.
before and after EMDR treatment, an expected average of 7 weeks of EMDR treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul Sehir University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Anticipated)

December 1, 2013

Study Completion (Anticipated)

February 1, 2014

Study Registration Dates

First Submitted

April 21, 2013

First Submitted That Met QC Criteria

May 6, 2013

First Posted (Estimate)

May 7, 2013

Study Record Updates

Last Update Posted (Estimate)

August 9, 2013

Last Update Submitted That Met QC Criteria

August 7, 2013

Last Verified

August 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2013/1No:4

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Trauma

Clinical Trials on Eye Movement Desensitization and Reprocessing Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe